Insider Trading & Ownership - Janux Therapeutics Inc. (JANX)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Janux Therapeutics Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-10-28
Sale
2024-10-30
7:30 pm
Janux Therapeutics Inc.JANXCampbell David Alan
President and CEO
25,000$53.54$1,338,559282,054
(Direct)
View
2024-09-13
Sale
2024-10-24
4:15 pm
Janux Therapeutics Inc.JANXLichter Jay
10% Owner
3,815$46.68$178,0846,618,252
(Indirect
Direct)
View
2024-10-18
Purchase
2024-10-22
4:20 pm
Janux Therapeutics Inc.JANXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
1,200,000$44.75$53,700,00010,365,652
(Indirect)
View
2024-10-16
Sale
2024-10-18
6:51 pm
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
1,673,128$46.3$77,472,3714,281,533
(Indirect
Direct)
View
2024-09-26
Sale
2024-09-30
8:49 pm
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
307,779$46.96$14,452,3943,005,777
(Indirect
Direct)
View
2024-09-27
Sale
2024-09-27
7:32 pm
Janux Therapeutics Inc.JANXMeyer Andrew Hollman
Chief Business Officer
50,000$45.96$2,297,755168,259
(Direct)
View
2024-09-27
Sale
2024-09-27
7:31 pm
Janux Therapeutics Inc.JANXDiRaimondo Thomas
Chief Scientific Officer
5,000$46.34$231,71697,938
(Direct)
View
2024-09-27
Sale
2024-09-27
7:30 pm
Janux Therapeutics Inc.JANXCampbell David Alan
President and CEO
25,000$46.31$1,157,641307,054
(Direct)
View
2024-09-10
Sale
2024-09-12
8:42 pm
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
451,091$46.89$21,153,6195,987,589
(Indirect
Direct)
View
2024-09-06
Sale
2024-09-10
5:02 pm
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
242,182$42$10,172,3643,297,625
(Indirect
Direct)
View
2024-06-03
Sale
2024-06-05
7:25 pm
Janux Therapeutics Inc.JANXLichter Jay
Director
10% Owner
1,500,000$54.75$82,125,0003,344,601
(Indirect
Direct)
View
2024-06-03
Sale
2024-06-05
7:23 pm
Janux Therapeutics Inc.JANXReardon Tighe
Acting Chief Financial Officer
822,721$54.75$45,043,9753,515,007
(Indirect
Direct)
View
2024-06-03
Sale
2024-06-05
7:19 pm
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
10% Owner
1,500,000$54.75$82,125,0006,611,234
(Indirect
Direct)
View
2023-11-13
Purchase
2023-11-15
4:48 pm
Janux Therapeutics Inc.JANXReardon Tighe
Acting Chief Financial Officer
10% Owner
849,854$5.87$4,988,6435,329,346
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-09-13
Exercise
2024-10-24
4:15 pm
N/A
N/A
Janux Therapeutics Inc.JANXLichter Jay
10% Owner
391$39.86,618,252
(Direct)
View
2024-09-13
Exercise
2024-10-24
4:15 pm
N/A
2027-07-19
Janux Therapeutics Inc.JANXLichter Jay
10% Owner
3,815$06,618,252
(Direct)
View
2024-09-13
Exercise
2024-10-24
4:15 pm
N/A
N/A
Janux Therapeutics Inc.JANXLichter Jay
10% Owner
1,868$176,618,252
(Direct)
View
2024-09-13
Exercise
2024-10-24
4:15 pm
N/A
N/A
Janux Therapeutics Inc.JANXLichter Jay
10% Owner
778$13.226,618,252
(Direct)
View
2024-09-13
Exercise
2024-10-24
4:15 pm
N/A
N/A
Janux Therapeutics Inc.JANXLichter Jay
10% Owner
778$10.736,618,252
(Direct)
View
2024-10-16
Exercise
2024-10-18
6:51 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
1,644$39.84,281,533
(Direct)
View
2024-10-16
Exercise
2024-10-18
6:51 pm
N/A
2027-07-19
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
12,284$04,281,533
(Direct)
View
2024-10-16
Exercise
2024-10-18
6:51 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
5,804$174,281,533
(Direct)
View
2024-10-16
Exercise
2024-10-18
6:51 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
2,418$13.224,281,533
(Direct)
View
2024-10-16
Exercise
2024-10-18
6:51 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
2,418$10.734,281,533
(Direct)
View
2024-09-27
Exercise
2024-09-30
8:49 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
357$39.83,005,777
(Direct)
View
2024-09-27
Exercise
2024-09-30
8:49 pm
N/A
2027-07-19
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
2,671$03,005,777
(Direct)
View
2024-09-27
Exercise
2024-09-30
8:49 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
1,262$173,005,777
(Direct)
View
2024-09-27
Exercise
2024-09-30
8:49 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
526$13.223,005,777
(Direct)
View
2024-09-27
Exercise
2024-09-30
8:49 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
526$10.733,005,777
(Direct)
View
2024-09-27
Exercise
2024-09-27
7:32 pm
N/A
2031-03-09
Janux Therapeutics Inc.JANXMeyer Andrew Hollman
Chief Business Officer
50,000$0168,259
(Direct)
View
2024-09-27
Exercise
2024-09-27
7:32 pm
N/A
N/A
Janux Therapeutics Inc.JANXMeyer Andrew Hollman
Chief Business Officer
50,000$4.21168,259
(Direct)
View
2024-09-09
Exercise
2024-09-10
5:02 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
277$39.83,297,625
(Direct)
View
2024-09-09
Exercise
2024-09-10
5:02 pm
N/A
2027-07-19
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
2,099$03,297,625
(Direct)
View
2024-09-09
Exercise
2024-09-10
5:02 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
994$173,297,625
(Direct)
View
2024-09-09
Exercise
2024-09-10
5:02 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
414$13.223,297,625
(Direct)
View
2024-09-09
Exercise
2024-09-10
5:02 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures I LP
Avalon BioVentures SPV I L.P.
Lichter Jay
10% Owner
414$10.733,297,625
(Direct)
View

Ownership
2024-08-09
7:06 pm
N/A
2031-03-09
Janux Therapeutics Inc.JANXDobek Maria
Vice President, Accounting
0$073,698
(Direct)
View
2024-07-19
Option Award(A)
2024-07-24
8:00 pm
N/A
2034-07-18
Janux Therapeutics Inc.JANXDOBMEIER ERIC
Director
5,342$010,342
(Direct)
View
2024-07-19
Option Award(A)
2024-07-24
8:00 pm
N/A
2034-07-18
Janux Therapeutics Inc.JANXHernday Natasha
Director
5,342$010,342
(Direct)
View
2024-07-19
Option Award
2024-07-22
8:04 pm
N/A
2034-07-18
Janux Therapeutics Inc.JANXDOBMEIER ERIC
Director
32,550$032,550
(Direct)
View
2024-07-19
Option Award
2024-07-22
8:03 pm
N/A
2034-07-18
Janux Therapeutics Inc.JANXHernday Natasha
Director
32,550$032,550
(Direct)
View
2024-06-26
Option Award
2024-06-28
4:35 pm
N/A
2034-06-25
Janux Therapeutics Inc.JANXRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
10,850$09,176,502
(Indirect)
View
2024-06-26
Option Award
2024-06-28
4:30 pm
N/A
2034-06-25
Janux Therapeutics Inc.JANXLichter Jay
Director
10% Owner
10,850$07,260,340
(Direct)
View
2024-06-26
Option Award
2024-06-28
4:30 pm
N/A
2034-06-25
Janux Therapeutics Inc.JANXMcNulty Alana B.
Director
10,850$010,850
(Direct)
View
2024-06-26
Option Award
2024-06-28
4:30 pm
N/A
2034-06-25
Janux Therapeutics Inc.JANXKung Winston
Director
10,850$010,850
(Direct)
View
2024-06-26
Option Award
2024-06-28
4:30 pm
N/A
2034-06-25
Janux Therapeutics Inc.JANXGujrathi Sheila
Director
10,850$0118,878
(Direct)
View
2024-06-26
Option Award
2024-06-28
4:30 pm
N/A
2034-06-25
Janux Therapeutics Inc.JANXBarrett Ronald W
Director
10,850$010,850
(Direct)
View
2024-06-26
Option Award
2024-06-28
4:30 pm
N/A
2034-06-25
Janux Therapeutics Inc.JANXSimson Jake
Director
10,850$010,850
(Direct)
View
2024-06-26
Option Award
2024-06-28
4:30 pm
N/A
2034-06-25
Janux Therapeutics Inc.JANXCAPPS VICKIE L
Director
10,850$076,393
(Direct)
View
2024-02-29
Other
2024-03-04
7:31 pm
N/A
N/A
Janux Therapeutics Inc.JANXAvalon Ventures XI L.P.
Avalon BioVentures SPV I L.P.
Avalon BioVentures I LP
10% Owner
1,016,200$05,009,239
(Direct)
View
2024-02-29
Other
2024-03-04
4:44 pm
N/A
N/A
Janux Therapeutics Inc.JANXGujrathi Sheila
Director
2,986$0111,014
(Direct)
View
2024-02-29
Other
2024-03-04
4:33 pm
N/A
N/A
Janux Therapeutics Inc.JANXCAPPS VICKIE L
Director
1,493$067,036
(Direct)
View
2024-01-02
Option Award
2024-01-03
4:54 pm
N/A
2034-01-01
Janux Therapeutics Inc.JANXWinter Charles M.
Chief Technical Officer
111,000$0111,000
(Direct)
View
2024-01-02
Option Award
2024-01-03
4:53 pm
N/A
2034-01-01
Janux Therapeutics Inc.JANXRobinson Byron
Chief Strategy Officer
151,500$0151,500
(Direct)
View
2024-01-02
Option Award
2024-01-03
4:52 pm
N/A
2034-01-01
Janux Therapeutics Inc.JANXReardon Tighe
Acting Chief Financial Officer
10% Owner
157,000$0157,000
(Direct)
View
2024-01-02
Option Award
2024-01-03
4:50 pm
N/A
2034-01-01
Janux Therapeutics Inc.JANXMeyer Andrew Hollman
Chief Business Officer
105,000$0105,000
(Direct)
View
2024-01-02
Option Award
2024-01-03
4:49 pm
N/A
2034-01-01
Janux Therapeutics Inc.JANXCampbell David Alan
President and CEO
356,500$0356,500
(Direct)
View
2024-01-02
Option Award
2024-01-03
4:47 pm
N/A
2034-01-01
Janux Therapeutics Inc.JANXDiRaimondo Thomas
Chief Scientific Officer
147,000$0147,000
(Direct)
View

Ownership
2024-01-03
4:45 pm
N/A
N/A
Janux Therapeutics Inc.JANXDiRaimondo Thomas
Chief Scientific Officer
0$0746,332
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, Next